Implant made of fibre-reinforced plastic

    公开(公告)号:US11589961B2

    公开(公告)日:2023-02-28

    申请号:US16336400

    申请日:2017-11-14

    IPC分类号: A61C8/00 A61C13/00

    摘要: A customizable implant made of plastic including a thermoplastic which is reinforced with long fibers arranged multidirectionally in a targeted manner and has a modulus of elasticity E of 10-70 GPa is provided. A system for producing a customizable implant including a device for collecting patient data regarding the environment into which an implant is to be inserted, a computer program for creating a model for a customized implant based on the patient data collected, and a device for producing the customized implant based on the calculated model by means of 3D printing and/or laser sintering is also provided.

    Temporary adhesive for metal-metal and metal-ceramic bonds
    3.
    发明授权
    Temporary adhesive for metal-metal and metal-ceramic bonds 失效
    金属 - 金属和金属 - 陶瓷键的临时粘合剂

    公开(公告)号:US07223808B2

    公开(公告)日:2007-05-29

    申请号:US10480917

    申请日:2002-06-14

    摘要: The invention relates to a method for the production of an adhesive and an adhesive kit for joining similar or different metal surfaces or ceramics, especially in the field of biomedicine. The objective of the invention is to avoid polymerization-linked by-products and disadvantageous effects, in addition to enabling a temporary biocompatible bond between metal and metal or metal and ceramics. The inventive method consist in using a monomer-free polymethylmethacrylate which is mixed with a suitable, non-toxic solvent and a bioactive vitreous-crystalline material with a particle size ranging from 0.05–20μ, consisting of 15–45 wt. % CaO, 40–45 wt. % P2O5, 10–40 wt. % ZrO2 and 0.7–3.5 wt. % fluoride, having apatite and calcium zircon phosphate as main crystal phases and a glass phase as an auxiliary component until a flowable mixture is obtained. The invention also relates to an adhesive kit consisting of said components. Sufficient amounts of resistance are obtained for a temporary bond, enabling the bond to be neutralized when desired.

    摘要翻译: 本发明涉及生产用于连接类似或不同金属表面或陶瓷的粘合剂和粘合剂试剂盒的方法,特别是在生物医学领域。 本发明的目的是除了能够在金属和金属或金属和陶瓷之间实现临时的生物相容性结合之外,避免聚合相互作用的副产物和不利影响。 本发明的方法包括使用无单体的聚甲基丙烯酸甲酯,其与合适的无毒溶剂和粒度范围为0.05-20mu的生物活性玻璃结晶材料混合,其由15-45wt。 %CaO,40-45wt。 %P 2 O 5,10-40重量% %ZrO 2和0.7-3.5wt。 具有磷灰石和磷酸钙锆作为主要结晶相的氟化物,玻璃相作为辅助成分,直到得到可流动的混合物。 本发明还涉及由所述组分组成的粘合试剂盒。 获得足够量的电阻用于临时键,使得当需要时可以中和该键。

    Method for producing a bioactive bone cement and bone cement kit
    4.
    发明授权
    Method for producing a bioactive bone cement and bone cement kit 失效
    生物活性骨水泥和骨水泥试剂盒的生产方法

    公开(公告)号:US07109254B2

    公开(公告)日:2006-09-19

    申请号:US10480886

    申请日:2002-06-14

    摘要: A method for producing a bioactive bone cement and a bone cement kit for anchoring artificial joints and for filling out bone defects. The method avoids polymerization-linked by-products and disadvantageous effects, while at the same time providing the bone cement with long-term stability. The inventive method uses a monomer-free polymethylmethacrylate, which is mixed with a suitable non-toxic solvent, and a bioactive, vitreous-crystalline material with a particle size ranging from >20 to 200 μm, having 15–45 wt. % CaO, 40–45 wt. % P2O5, 10–40 wt. % ZrO2 and 0.7–3.5 wt. % fluoride, having apatite and calcium zircon phosphate as main crystal phases and a glass phase as an auxiliary component until a flowable mixture is obtained. The invention also relates to a bone cement kit having said components.

    摘要翻译: 生物活性骨水泥的制造方法和用于锚定人造关节并填充骨缺损的骨水泥试剂盒。 该方法避免了与聚合有关的副产物和不利影响,同时为骨水泥提供长期的稳定性。 本发明的方法使用与合适的无毒溶剂混合的无单体聚甲基丙烯酸甲酯和粒度范围> 20至200μm的生物活性玻璃态结晶材料,其具有15-45wt。 %CaO,40-45wt。 %P 2 O 5,10-40重量% %ZrO 2和0.7-3.5wt。 具有磷灰石和磷酸钙锆作为主要结晶相的氟化物,玻璃相作为辅助成分,直到得到可流动的混合物。 本发明还涉及具有所述组分的骨水泥试剂盒。

    Surface treated metallic implant and blasting material
    8.
    发明授权
    Surface treated metallic implant and blasting material 失效
    表面处理金属植入物和爆破材料

    公开(公告)号:US07377943B2

    公开(公告)日:2008-05-27

    申请号:US10480918

    申请日:2002-06-14

    摘要: The invention relates to a metallic implant, which has vitreous-crystalline bioactive material on the surface thereof. According to the invention, a metallic implant base body arranged on the surface of the particles has a bioactive, vitreous-crystalline material consisting of 15-45 wt. % CaO, 40-45 wt. % P2O5, 10-40 wt. % ZrO2 and 0.7-3.5 wt. % fluoride, having apatite and calcium zirconium phosphate as main crystalline and a glass phase as an auxiliary component. Said vitreous crystalline material contains at least 35 wt. % main crystal phases and at least 5-15 wt. % auxiliary compounds. All of the percentage data is expressed in relation to the total weight of the vitreous crystalline material and the particle size of the vitreous crystalline material is between 60-350 μm.

    摘要翻译: 本发明涉及一种在其表面上具有玻璃态生物活性物质的金属植入物。 根据本发明,布置在颗粒表面上的金属植入物基体具有生物活性的玻璃状结晶材料,其由15-45wt。 %CaO,40-45wt。 %P 2 O 5,10-40重量% %ZrO 2和0.7-3.5wt。 %氟化物,磷灰石和磷酸钙锆为主晶,玻璃相为辅助成分。 所述玻璃态结晶材料含有至少35wt。 %主晶相和至少5-15wt。 %辅助化合物。 所有百分比数据都以玻璃态结晶材料的总重量表示,玻璃状结晶材料的粒径在60-350μm之间。